NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001650

Registered date:22/01/2009

A prospective,multicenter, randomized, parallel-group,open-label study of aripiprazole in the management of patients with schizophrenia

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedSchizophrenia
Date of first enrollment2009/01/01
Target sample size300
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Aripiprazole Standard control

Outcome(s)

Primary OutcomePreference of Medicine(POM)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum65years-old
GenderMale and Female
Include criteria
Exclude criteriaPregnant or breastfeeding women. Not noticed as schizophrenia. With diabetes.

Related Information

Contact

public contact
Name Tomihisa Niitsu
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone 043-226-2148
E-mail niitsu@chiba-u.jp
Affiliation Graduate School of Medicine, Chiba University Department of Psychiatry
scientific contact
Name Masaomi Iyo
Address 1-8-1 Inohana, Chuo-ku, Chiba Japan
Telephone 043-226-2148
E-mail iyom@faculty.chiba-u.jp
Affiliation Graduate School of Medicine, Chiba University Department of Psychiatry